SBFM Q2 2018 Earnings — Sunshine Biopharma, Inc. Revenue & Financial Results | Market Cap Arena

SBFMSunshine Biopharma, Inc.

$6M

Q2 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$107,250

Gross Profit

$15,61914.6% margin

Operating Income

-$580,511-541.3% margin

Net Income

-$644,308-600.8% margin

EPS (Diluted)

$-12.88

QoQ Revenue Growth

+17.6%

Cash Flow

Operating Cash Flow

-$124,443

Free Cash Flow

-$147,030

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$1M

Total Liabilities

$1M

Stockholders' Equity

-$276,130

Cash & Equivalents

$36,395

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$107,250	$0	—
Gross Profit	$15,619	$0	—
Operating Income	-$580,511	-$472,218	-22.9%
Net Income	-$644,308	-$485,444	-32.7%